Skip to main content
NCBI home page
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2021 Nov 16;8:729138. doi: 10.3389/fmed.2021.729138

Bibliometric Analysis and Systematic Review of Global Coronavirus Research Trends Before COVID-19: Prospects and Implications for COVID-19 Research

Peijing Yan 1,2,†, Meixuan Li 2,3,†, Jing Li 3,2, Zhenxing Lu 4, Xu Hui 3,2, Yuping Bai 5,6,7, Yangqin Xun 2,8,9, Yongfeng Lao 10, Shizhong Wang 11,*, Kehu Yang 2,3,8,9,*
PMCID: PMC8635101  PMID: 34869424

Abstract

Coronaviruses (CoV) cause respiratory and intestinal infections. We conducted this bibliometric analysis and systematical review to explore the CoV-related research trends from before COVID-19. We systematically searched the Ovid MEDLINE, Ovid Embase, and Web of Science (WOS) databases for published bibliometric analyses of CoV from database inception to January 24, 2021. The WOS Collection was searched from inception to January 31, 2020, to acquire the CoV-related publications before COVID-19. One-Way ANOVA and Bonferroni multiple-comparison tests were used to compare differences. Visualization mapping and keyword cluster graphs were made to illustrate the research topics and hotpots. We included 14,141 CoV-related publications for the bibliometric analysis and 16 (12 articles) CoV-related bibliometric analyses for the systematic review. Both the systematic review and bibliometric analysis showed (1) the number of publications showed two steep upward trajectories in 2003–2004 and in 2012–2014; (2) the research hotpots mainly focused on the mechanism, pathology, epidemiology, clinical diagnosis, and treatment of the coronavirus in MERS-CoV and SARS-Cov; (3) the USA, and China; the University of Hong Kong; and Yuen KY, came from the University of Hong Kong contributed most; (4) the Journal of Virology had the largest number of CoV related studies. More studies should focus on prevention, diagnosis, and treatment in the future.

Keywords: Coronaviruses, COVID-19, bibliometric analysis, systematic review, contribution, research topics

Introduction

Coronaviruses (CoV) are a large family of positive-sense single-stranded RNA viruses that cause illnesses ranging from the common cold to more severe diseases (1, 2). Some CoV are zoonotic and can cause respiratory and intestinal infections in animals and humans (3), and have even resulted in lethal endemics, such as Middle East Respiratory Syndrome Coronaviruses (MERS-CoV), Severe Acute Respiratory Syndrome Coronaviruses (SARS-CoV), and Coronavirus Disease 2019 (COVID-19) (4).

With the outbreak and epidemic of CoV-related diseases, an increasing number of studies discussed the epidemic characteristics, diagnosis, infection mechanisms, and prevention of CoV (4–8). The appearance of COVID-19 was accelerating such research, which was certainly unique in the history of science and led to an explosion of research output. This output includes many meaningful approaches, but some appear to be excessive and not scientifically sound (9, 10). Against this background, it is very necessary to think about these compelling questions: Can we learn from previous research patterns regarding CoV? What influence do they have on future research? How can we use past efforts, their intensification, and the influences of research on CoV positively to better understand the needs for sustainable and appropriate research? (9). Therefore, it is very important to know about the global research on CoV in the time before COVID-19.

Systematically summarizing and analyzing the research of the CoV is helpful to understand the current state of research and provide references for future research. Bibliometric analysis is a statistical tool that is used to quantitatively and qualitatively measure and evaluate scientific publications (11–13). It consists of a review of the literature, and indicates the number, evaluation, and main trends of publications concerning a specific subject (14, 15).

To the best of our knowledge, there have been two bibliometric studies on CoV-related research in English before the COVID-19 pandemic (16, 17). One study published in 2016 assessed the characteristics of publications only focused on the MERS-CoV (18). Another study (19) analyzed the global research trends of the World Health Organization's top eight emerging infections including Ebola, Marburg, MERS, Severe Acute Respiratory Syndrome (SARS), and so on, but publications related to CoV were not systematically analyzed. A letter to the editor had simply investigated the publication characteristics of SARS-CoV, MERS-CoV, and COVID-19, but it only analyzed the number of publications and countries, which might not be enough to provide a reference for future research (20). In addition, several studies on coronavirus research trends were published in the time before the COVID-19 pandemic. However, some of the research focused on the specific periods, such as 2003 to March 2020. Therefore, we did a bibliometric analysis of all the publications before COVID-19. Additionally, these studies were based on various timespan and databases, and the findings did not well agree. We did this systematic review to summarize the findings of all the current bibliometric analyses in this topic to provide references for researchers focused on the emerging human CoV, and to provide ideas for finding effective control measures, drugs, and vaccines.

Methods

This is a bibliometric analysis and systematic review, and the data we used were extracted from publications. Therefore, this study has no discernible ethical issues.

Data Source and Search Strategy

We searched PubMed, Cochrane Library, and Embase databases using the Medical Subject Headings (MeSH) to acquire the CoV-related terms. For the bibliometric analysis, we searched publications using these terms in the Web of Science (WOS) Core Collection from its inception to January 31, 2020. In terms of the systematic review, we systematically searched the Ovid MEDLINE, Ovid Embase, and WOS databases using terms relating to CoV and bibliometric analysis, for published bibliometric analysis from database inception to January 24, 2021. The detailed search strategy is displayed in Appendix (Appendix, Supplementary Tables 1, 2). No limitation was used. As the metrics are changing over time, all the searches and data exports were completed on the same day to avoid the possible bias caused by frequent updates of the databases.

Eligibility Criteria for Systematic Review

This systematic review included the bibliometric analyses of global CoV research trends. We excluded the bibliometric analyses without any indicators of publication and citation, journal, country or territory, affiliation and international cooperation, author, or subject/research topic. We also excluded conference abstracts, editorials, reviews, meta-analyses, and case reports or case series, as well as non-English and non-Chinese language publications and publications reporting duplicate data.

Data Collection and Cleaning

In terms of bibliometric analysis, we obtained (1) the characteristics of all the retrieved publications; (2) the 2019 journal impact factor (JIF) (21), 5 year JIF (21), and publication counts of the journals; (3) publication count per year, h-index, various citation values [average citations per item (ACPI), sum of times cited (STC) and No. citations of most-cited item (NCMCI)] and top-5 most-publications research areas (top-5 research areas) of the top-10 most-publications countries (top-10 countries); and (4) institutes, h-index, various citation values, and top-5 research areas of the top-10 most-publications authors (top-10 authors). All documents were downloaded in tab separator format.

We standardized the keywords with the same meaning but in different styles. For example, “coronavirus” was replaced by “coronavirus (cov)”, “middle east respiratory syndrome coronavirus” was replaced by “MERS”, etc.

As for the systematic review, one researcher (Y-PB) extracted the information from the included studies using a pre-piloted, standardized extraction table, and the other researcher (P-JY) checked the extraction. Any discrepancies between the reviewers were resolved by discussion. We extracted the following information: (1) study characteristics (first author, publication year, country, journal); (2) search strategies, and (3) indicators or findings on publication and citation, journal, country or territory, affiliation and international cooperation, author, subject/research topics, and keyword co-occurrence cluster.

Since there is no validated quality assessment tool that can be applied to bibliometric analyses, we did not assess the risk of bias or the methodological quality for the included bibliometric analyses.

Statistical Analysis

The data were entered into a spreadsheet program (Microsoft Excel 2016, Microsoft, Washington, USA). The statistical analyses and preparation of the figures were performed using Stata, version 15 (Stata Corp, College Station, TX, USA). For all statistical tests, a two-tailed α level of 0.05 was used.

We used VOSviewer 1.6.1 (Centre for Science and Technology Studies, Leiden University, Leiden, The Netherlands) to analyze the publication characteristics (22, 23). Keywords co-occurrence can effectively reflect the research hotspots in the discipline fields, providing auxiliary support for scientific research (24). VOSviewer was also used for visualization mapping to present co-authorship and co-occurrence networks (25) and generate keywords clustering graph to present the research topic.

Results

Basic Characteristics of CoV–Related Publications

A total of 14,141 publications were retrieved, of which around 77.27% were published as original articles, 8.36 % as reviews, 3.91% as proceedings papers, 3.13% as meeting abstracts, with the remaining being book chapters, etc., (Appendix, Supplementary Figure 1). For the book chapters, the Advances in Experimental Medicine and Biology (273), Advances in Virus Research (26), and Current Topics in Microbiology and Immunology (27) were the top-3 most-publications, others were less than 10 records.

Among these publications, 53.35% (7,544) records did not contain data in the funding agencies; 97.24 % (13,750) were published in English, 0.79 % (111) were in French, 0.75 % (106) were in German, and the remaining were in Spanish, Chinese, and 14 other languages.

The Annual Trends of CoV–Related Publications

Figure 1 plots the annual trends of CoV-related publications. Since the first literature was published in 1980, CoV-related research had a very slow increase in the following 20 years. The number of publications grew very sharply in 2003, hit a peak in 2004 (843), and then declined gradually until another sudden increase in 2012 (Figure 1).

Figure 1.

Figure 1

Open in a new tab

Annual trends of CoV-related publications.

Journals of CoV–Related Publications

The CoV-related publications were published in 500 journals. The 24 journals with more than 100 publications were listed. The journal with the most publications was the Journal of Virology (1,240), followed by Virology (546) and the Journal of General Virology (352). The 2019 JIF ranged from 1.306 (Avian Disease) to 9.580 (Proceedings of The National Academy of Science of The United States of America), and the 5 year JIF ranged from 1.330 to 10.600 (Figure 2).

Figure 2.

Figure 2

Open in a new tab

Journals with more than 100 CoV-related publications.

Countries and Regions of CoV–Related Publications

A total of 134 countries published CoV-related studies. Around 32.49% of those publications were published in North America, 31.49% in Europe, 30.78% in Asia, and the remaining in Oceania, South America, and other regions (Appendix, Supplementary Figure 2). The cooperation network analysis included 88 countries, which with a frequency ≥ 5 times. The density map showed that the top-10 countries were the United States of America (USA) with 5,142, followed by China (2,754), Germany (961), Canada (887), England (880), Netherlands (788), Japan (710), France (647), South Kores (438), and Taiwan (China) (422) (Figure 3A). Among the top-10 countries, 1/5 were from North America, 2/5 from Asia, and the rest from Europe (Table 1). The CoV-related publication count of the top-10 countries over the 41 years is listed in Appendix (Appendix, Supplementary Table 3).

Figure 3.

Figure 3

Open in a new tab

Country (A) and institution (B) co-authorship network of CoV-related publications.

Table 1.

Characteristics of top-10 countries (N = 14,141).

ID Country N (%) Region NCMCI Top-5 Research areas
1 USA 5,142 (36.36) North America 1,823 Virology; Immunology; Veterinary Sciences; Microbiology; Biochemistry Molecular Biology
2 China 2,754 (19.48) Asia 1,823 Virology; Biochemistry Molecular Biology; Immunology; Infectious Diseases; Microbiology
3 Germany 961 (6.80) Europe 1,732 Virology; Immunology; Biochemistry Molecular Biology; Veterinary Sciences; Infectious Diseases
4 Canada 887 (6.27) North America 1,273 Virology; Immunology; Veterinary Sciences; Biochemistry Molecular Biology; Infectious Diseases
5 England 880 (6.22) Europe 1,328 Virology; Veterinary Sciences; Infectious Diseases; Biochemistry; Molecular Biology Immunology
6 Netherlands 788 (5.57) Europe 1,732 Virology; Microbiology; Infectious Diseases; Immunology; Biochemistry Molecular Biology
7 Japan 710 (5.02) Asia 794 Virology; Veterinary Sciences; Immunology; Microbiology; Biochemistry Molecular Biology
8 France 647 (4.58) Europe 1,732 Virology; Infectious Diseases; Veterinary Sciences; Immunology; Microbiology
9 South Korea 438 (3.10) Asia 320 Virology; Infectious Diseases; Veterinary Sciences; Microbiology; Immunology
10 Taiwan
(China)		 422 (2.98) Asia 1,823 Biochemistry Molecular Biology; Virology; Infectious Diseases; Pharmacology Pharmacy; Immunology
Open in a new tab

NCMCI, No. citations of most-cited item.

Among these countries, a total of 6,753 institutions were involved in CoV-related publications. A network of 530 institutions with a frequency ≥ 10 was formed. The University of Hong Kong (China), the Chinese Academy of Sciences (China), Utrecht University (Netherlands), the University of Southern California (USA), and the University of Pennsylvania (USA) were at the center of the cooperation network and formed close cooperative relationships with other institutions (Figure 3B).

In terms of STC, h-index, and NCMCI of the top-10 countries, the USA was the most-contributed country with the highest h-index (156), STC (185,165), and NCMCI (1,823), followed by the Netherlands (107) and China (105) in h-index, China (73,101) and the Netherlands (47,486) in STC, and China (1,823) and Taiwan (1,823) in NCMCI (Table 1).

The CoV-related publications of the top-10 countries mainly focused on the following research areas: virology, veterinary sciences, infectious diseases, immunology, biochemistry molecular biology, microbiology, and pharmacology (Table 1, Appendix, Supplementary Figure 3). The most-contributed research area of the top-10 countries was virology, except for Taiwan, which focused on biochemistry molecular biology. The Netherlands contributed more to the virology area than any of the other nine countries (Appendix, Supplementary Figure 3).

Authors of CoV–Related Publications

A total of 43,476 authors were involved in the CoV-related publications, 402 authors with a frequency ≥ 10 times were included in the collaboration network analysis, and 27 cooperation networks were formed. Yuen KY (China), Baric RS (USA), and Drosten C (Germany) had the highest number of publications and were in the middle of the network diagram, which shows that they formed close cooperative relationships with other authors (Figure 4).

Figure 4.

Figure 4

Open in a new tab

Co-authorship network of CoV-related publications.

The top-10 authors with the most CoV-related publications mainly came from the USA (1/2) and China (1/5), and were focused in the University of Southern California and the University of Hong Kong (Table 2). Most of the top-10 authors came from the departments of microbiology (Table 2) and mainly focused on virology, microbiology, infectious diseases, immunology, and seven other research areas (Figure 5, Table 2). The most-contributed research area of the top-10 authors was virology, except Drosten C who focused on infectious diseases (Figure 5).

Table 2.

Characteristics of the top-10 authors.

ID Author N (%) Organization H-Index Citation Top-5 Research areas
Country Institute Department ACPI STC NCMCI
1 Yuen KY 213 (1.51) China University of Hong Kong Department of Microbiology and Pathology 67 76.10 16,210 1,436 Virology; Microbiology;
Infectious Diseases; Immunology;
Biochemistry Molecular Biology
2 Perlman S 187 (1.32) USA University of Iowa Department of Microbiology 44 32.13 6,008 321 Virology; Microbiology;
Biotechnology Applied Microbiology;
Research Experimental Medicine;
Biochemistry Molecular Biology
3 Baric RS 170 (1.20) USA University of North Carolina Department of Epidemiology 53 43.61 7,413 321 Virology; Veterinary Sciences;
Immunology; Infectious Diseases;
Biochemistry Molecular Biology
4 Enjuanes L 162 (1.15) Spain Centro Nacional de Biotecnologia Department of Molecular and Cell Biology 48 40.62 6,580 350 Virology; Microbiology;
Biotechnology Applied Microbiology;
Research Experimental Medicine;
Biochemistry Molecular Biology
5 Stohlman SA 156 (1.10) USA University of Southern California Departments of Microbiology and Neurology 52 48.13 7,508 266 Virology; Veterinary Sciences;
Immunology; Infectious Diseases;
Biochemistry Molecular Biology
6 Weiss SR 156 (1.10) USA University of Pennsylvania School of Medicine Department of Microbiology 44 33.74 5,263 237 Virology; Neurosciences Neurology;
Research Experimental Medicine;
Microbiology; Immunology
7 Drosten C 144 (1.02) Germany National Reference Center for Tropical Infectious Diseases Bernhard Nocht Institute for Tropical Medicine 48 76.30 10,987 1,732 Infectious Diseases; Virology;
Immunology; Microbiology;
Science Technology Other Topics
8 Rottier PJM 134 (0.95) Netherlands Utrecht University Department of Infectious Diseases & Immunology 50 56.95 7,631 459 Virology;
Biochemistry Molecular Biology;
Biotechnology Applied Microbiology; Microbiology;
Cell Biology
9 Woo PCY 127 (0.90) China University of Hong Kong Department of Microbiology 47 58.57 7,438 646 Virology; Microbiology;
Immunology; Infectious Diseases;
Biotechnology Applied Microbiology
10 Lai MMC 123 (0.87) USA University of Southern California Department of Molecular Microbiology and Immunology 56 67.42 8,293 545 Virology;
Biochemistry Molecular Biology;
Cell Biology; Microbiology;
Research Experimental Medicine
Open in a new tab

ACPI, Average citations per item; STC, Sum of times cited; NCMCI, No. citations of most-cited item.

Figure 5.

Figure 5

Open in a new tab

Proportion of top-5 research areas for the top-10 authors.

Yuen KY had the highest number of publications, h-index, and STC, followed by Perlman S and Baric RS in number of publications, Lai MMC and Baric RS in h-index, and Drosten C and Lai MMC in STC. Drosten C had the highest NCMCI and ACPI, followed by Yuen KY and Woo PCY in NCMCI and Yuen KY and Lai MMC in ACPI (Table 2).

Research Topics of CoV–Related Publications

A total of 23,732 keywords were included in the 14,141 publications, and 973 keywords with occurrence frequency ≥ 20 were clustered. In the cluster figure, one type of color represents one cluster, and a total of five main clusters were formed, indicating that the current CoV-related research concentrated on the following five topics: Topic 1 (red area, 239 items): the detection and identification of SARS-CoV by collecting nucleic acid and protein of virus in vitro; Topic 2 (green area, 211 items): research on the natural history, transmission, and diagnosis of CoV; Topic 3 (blue area, 166 items): research on SARS-CoV outbreaks in China, and the MERS-CoV outbreak in Saudi Arabia; Topic 4 (yellow area, 138 items): research on the mechanisms of viral infection and expression in in vitro cells and lab mice; and Topic 5 (purple area, 133 items): research on pneumonia caused by human infection with CoV and the spread, prevalence, and burden of various diseases caused by infection with other viruses such as avian influenza (Figure 6).

Figure 6.

Figure 6

Open in a new tab

Keyword co-occurrence network in CoV-related publications.

The density map of 973 keywords is presented in the Appendix (Appendix, Supplementary Figure 4). “CoV (3,116 items),” “infection (1,413 items),” “identification” (1,393 items), etc. had the highest frequency in the red area, followed by “diagnosis (395 items),” and the “therapy (69 items)” in the yellow area and “treatment (35 items)” in the green area (Appendix, Supplementary Figure 4).

High-Frequent Citation Articles

Most of the top-10 most-cited publications came from the USA and were in high impact-factor journals such as New England Journal of Medicine, British Medical Journal, and Science. The most frequently cited article (1,823 citations) was published by Ksiazek et al. (28), followed by Drosten et al. (29) (1,732 citations) (Table 3).

Table 3.

The top-10 most-cited publications.

ID Title Publication year First author Country Institution STC Journal
1 A novel coronavirus associated with severe acute respiratory syndrome 2003 Ksiazek TG USA CDC, the Special Pathogens Branch 1,823 NEJM
2 Identification of a novel coronavirus in patients with severe acute respiratory syndrome 2003 Drosten C Germany The Bernhard Nocht Institute for Tropical Medicine 1,732 NEJM
3 Characterization of a novel coronavirus associated with severe acute respiratory syndrome 2003 Rota PA USA National Center for Infectious Diseases, CDC 1,487 Science
4 Coronavirus as a possible cause of severe acute respiratory syndrome 2003 Peiris JSM China University of Hong Kong, Queen Mary Hospital 1,436 Lancet
5 Community study of role of viral infections in exacerbations of asthma in 9–11 years old children 1995 Johnston SL British University Medicine, Southampton General Hospital 1,328 BMJ
6 Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia 2012 Zaki AM Saudi Arabia The Dr. Soliman Fakeeh Hospital 1,274 NEJM
7 The genome sequence of the SARS-associated coronavirus 2003 Marra MA British BCCA, Genome Sciences Centre 1,273 Science
8 Cloning of a human parvovirus by molecular screening of respiratory tract samples 2005 Allander N T Sweden Karolinska University Hospital 1,011 PNAS
9 Psychological Stress and Susceptibility to the Common Cold 1991 Cohen S USA Carnegie Mellon University 1,004 NEJM
10 Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus 2003 Li WH USA Division of Pulmonary Medicine and Ina Sue Perlmutter Laboratory 968 Nature
Open in a new tab

STC, Sum of times cited; CDC, Centers for Disease Control and Prevention; NEJM, New England Journal of Medicine; BMJ, British Medical Journal; PNAS, Proceedings of the National Academy of Sciences of the United States of America.

Systematic Review of Published Bibliometric Analyses

Study Characteristics of Published Bibliometric Analyses

A total of 17 (9, 11, 26, 27, 30–38) CoV-related bibliometric analyses from 13 articles were included, of which one study (27) conducted five bibliometric analyses. All 17 bibliometric analyses were published in 2020 and included between 641 and 15,207 primary studies (Table 4). Two included articles from India (26, 38), one from Spain (34), one from Turkey (27), two from Israel (9, 31), and the remaining 7 reports were from China (Appendix, Supplementary Table 4). All the 13 included articles were published in journals with IF from 0 to 5.993 (Appendix, Supplementary Table 4). Most of the CoV-related bibliometric analyses (88.2%, 15/17) retrieved data from the WOS up to 2020, and the types of original studies included were mainly articles and reviews. A majority of the CoV-related bibliometric analyses indicated that the annual publication count increased due to three notable epidemic events in history.

Table 4.

The characteristics and top-3 information of published bibliometric analyses.

References Search date-search deadline Dataset No. publications The Top-3 Journal The Top-3 Countries or territories (n, %) The Top-3 Institutions (n) The Top-3 Authors
(11) Database inception to Feb-20 Scopus 15207 1. JVI; 2. EID; 3. Lancet 1. USA (4,225, 27.8%);
2. China (mainland) (2,720, 17.9%);
3. China (Hong Kong) (1,411, 9.3%)		 1. University of Hong Kong, China (703);
2. Chinese University of Hong Kong, China (499);
3. Chinese Academy of Sciences, China (407)		 1. Yuen KY, University of Hong Kong, China (180);
2. Drosten C, Charité-Universitätsmedizin Berlin, Germany (128);
3. Peiris JSM, University of Hong Kong, China (111)
(33) Jun-05 to Feb-20 WOSCC 9760 1. JVI;
2. Virology;
3. PLoS One		 1. USA (3,452, 35.4%);
2. China (2,402, 24.6%);
3. Germany (642, 6.6%)		 1. University of Hong Kong, China (959);
2. Chinese Academy of Sciences, China (469);
3. Chinese University of Hong Kong, China (411)		 1. Yuen KY, University of Hong Kong, China (200);
2. Baric RS, University of North Carolina, USA (134);
3. Perlman S, University of Iowa, USA (133)
(9) Database inception to Mar-20 WOSCC 6905 NR 1. USA (2,293, 33.2%);
2. China (1,707, 24.7%);
3. Germany (505, 7.3%)		 1. University Hong Kong, China (398);
2. Chinese University Hong Kong, China (217);
3. CDC, USA (155)		 NR
(36) Jan-03 to Apr-20 WOSCC 11036 1. JVI;
2. EID;
3. Virology		 1. USA (3,606, 32.7%);
2. China (3,139, 28.4%);
3. Germany (669, 6.1%)		 1. University of Hong Kong (595); Chinese University of Hong Kong (311);
2. CDC (266)		 1. Yuen, KY, University of Hong Kong, China (214);
2. Drosten C, University of Bonn, Germany (142);
3. 3. Baric RS., University of North Carolina, USA (131)
(37) Jan-00 to Mar 20 WOSCC 9105 1. JVI;
2. Virology;
3. PLoS One		 1. USA (3,101, 34.3%);
2. China (2,230, 24.7%);
3. Germany (584, 6.5%)		 1. University of Hong Kong, China (434);
2. Chinese Academy of Science, China (329);
3. University of California System, USA (246)		 NR
(30) Jan-03 to Feb-20 WOSCC 8433 NR 1. USA (2,791, 33.1%);
2. China (2,231, 26.5%);
3. Germany (564, 6.7%)		 1. University of Hong Kong, China (399);
2. Chinese Academy Sciences, China (298);
3. CDC, USA (184)		 1. Yuen KY, University of Hong Kong, China (178);
2. Drosten C, University of Bonn, Germany (118);
3. Baric RS, University of North Carolina, USA (114)
(32) Jan-03 to Feb-20 WOSCC 9294 1. JVI;
2. Virology;
3. Virus Research		 1. USA (3,225, 34.7%);
2. China (2,410, 25.9%);
3. Germany (621, 6.7%)		 1. University of Hong Kong, China (452);
2. Chinese Academy of Sciences, China (323);
3. CDC, USA (197)		 1. Yuen KY, University of Hong Kong, China (TLS=598 times);
2. Chan KH, (TLS=411 times);
3. Woo PCY, University of Hong Kong, China (TLS=382 times)
(27) Jan-80 to Dec-19 WOSCC 13833 1. JVI;
2. Virology;
3. ADV EXP MED BIOL		 1. USA (4,894, 35.4%);
2. China (16.7%);
3. Germany (6.7%)		 1. University of Hong Kong, China (534);
2. Chinese Academy of Sciences, China (396);
3. Utrecht University, Netherlands (335)		 1. Yuen KY, University of Hong Kong, China (218);
2. Perlman S, University of Iowa, USA (189);
3. Enjuanes L, Autonomous University of Madrid, Spain (176)
(27) Jan-80 to Dec-19 WOSCC 641 JGV 1. USA (36.7%);
2. Germany
(13.4%);
3. UK (12.2%)		 University of Würzburg, Germany Termeulen V
(27) Jan-80 to Dec-19 WOSCC 1674 JVI 1. USA (44.3%);
2. Germany (9.0%);
3. Canada (8.3%)		 University of Southern California, USA (96) Lai MMC, University of Southern California, USA (70)
(27) Jan-80 to Dec-19 WOSCC 4810 1. JVI;
2. Virology;
3. ADV EXP MED BIOL		 1. USA (1,679, 34.9%);
2. China (1,202, 25.0%);
3. Canada (324, 6.7%)		 1. University of Hong Kong, China (284);
2. Chinese Academy of Sciences, China (221);
3. Chinese University of Hong Kong, China (172)		 Yuen KY, University of Hong Kong, China (110)
(27) Jan-80 to Dec-19 WOSCC 6601 NR 1. USA (2,218, 33.6%);
2. China (1,479, 22.4%);
3. Germany (436, 6.6%)		 1. University of Hong Kong, China (243);
2. National Institutes of Health, USA (184);
3. Chinese Academy of Sciences, China (170)		 Drosten C, Charité – Universitätsmedizin, Germany (113)
(26) Jan-68 to Mar-20 WOS 6424 1. JVI;
2. JGV;
3. Virology		 1. USA (2,345, 36.5%);
2. China (1,067, 16.6%);
3. Germany (480, 7.5%)		 1. University of Hong Kong, China (506);
2. University of North Carolina, USA (412);
3. Chinese Academy of Sciences, China (371)		 NR
(34) Jan-70 to Apr-20 WOS 12571 1. JVI;
2. Virology;
3. ADV EXP MED BIOL		 1. USA (4,513, 35.9%);
2. China (2,746, 21.8%);
3. UK (962, 7.7%)		 1. University of Hong Kong, China (487);
2. Chinese Academy of Sciences, China (373);
3. University of California System, USA (321)		 1. Yuen KY, University of Hong Kong, China (201);
2. Perlman S, University of Iowa, USA (169);
3. Baric RS, University of North Carolina (162); Enjuanes L, Autonomous University of Madrid, Spain (162)
(31) Jan-02 to NR MAG; PubMed; SJR; Wikidata NR NR NR NR NR
(35) Database inception to Feb-20 WOSCC 1747 NR 1. USA (613, 35.4%);
2. China (582, 33.6%);
3. Germany (122, 7.1%)		 1. Chinese Academy of Sciences, China (82);
2. University of Hong Kong, China (74);
3. Chinese University of Hong Kong, China (58)		 1. Baric RS, University of North Carolina (21);
2. Yuen KY, University of Hong Kong, China (17); Snijder EJ, Netherlands (17); Kuochen Chou, USA (17);
3. Jiang Shibo, China (16)
(38) Jan-00 to Dec-19 WOS 10816 1. JVI;
2. Virology;
3. EID		 1. USA (3,755, 34.6%);
2. China (2,618, 24.1%);
3. Germany (737, 6.8%)		 1. University of Hong Kong, China (511);
2. Chinese Academy of Sciences, China (385);
3. National Institute of Health, USA (270)		 1. Yuen, KY, Pamela Youde Nethersole Eastern Hospital, Hong Kong (210);
2. Perlman, S, University of Iowa, USA (148);
3. Drosten, C, Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg, Germany (144)
Open in a new tab

WOSCC, The Web of Science Core Collection; WOS, Web of Science; JVI, Journal of Virology; JGV, Journal of General Virology; EID, Emerging Infectious Diseases; CDC, Center for Disease Control and Prevention; NR, not reported; MAG, Microsoft Academic Graph; ADV EXP MED BIOL, Advances in Experimental Medicine and Biology; SJR, Scientific Journal Rankings; PNAS, Proceedings of the National Academy of Sciences of the United States of America; TLS, total link strength.

Journals, Countries, Institutions, and Authors of CoV-Related Publications in Published Bibliometric Analysis

Six (11, 26, 33, 36–38) of 17 included bibliometric analyses reported the total number of CoV-related research journals (100–3,443), 11 bibliometric analyses (8 articles) (11, 26, 27, 32–34, 36, 37) listed the top 1–20 journals, and all of them reported that the Journal of Virology had the largest number of CoV-related studies (Table 4, Appendix, Supplementary Table 5).

In terms of countries, 6 bibliometric analyses (30, 32, 33, 36–38) reported the total number of CoV-related research by country (78–219), and nearly all of them listed the top 20 most-publications countries countries. In 16 of the 17 bibliometric analyses (9, 11, 26, 27, 30, 32–38) it was indicated that the USA had the largest number of CoV-related publications, followed by China, and their cooperative network diagram showed the most frequent cooperation occurred in the USA and China (Table 4, Appendix, Supplementary Table 5).

As for institutions, 4 bibliometric analyses (30, 33, 35, 38) reported the total number of CoV-related research institutions (147, 242, 333, 6,306 respectively), and 12 bibliometric analyses (9, 11, 26, 27, 30, 32–34, 36–38) indicated that the University of Hong Kong had the largest number of CoV-related publications. Only 5 bibliometric analyses (30, 32, 33, 35, 36) analyzed cooperation among institutions, and their conclusions were inconsistent (Table 4, Appendix, Supplementary Table 5).

Regarding authors, 4 bibliometric analyses (30, 32, 33, 35) reported the total number of CoV-related research authors (121-29515), 12 bibliometric analyses listed top-20 authors (11, 27, 30, 32–36, 38), and 9 of them (11, 27, 30, 32–34, 36, 38) indicated that Yuen KY at the University of Hong Kong had the largest number of CoV-related publications. Collaboration between authors and highly cited authors were not fully analyzed in the included studies, and were only mentioned in 4 bibliometric analyses (30, 33, 35, 36) (Table 4, Appendix, Supplementary Table 5).

Research Topics of CoV-Related Publications in Published Bibliometric Analysis

Four included bibliometric analyses (9, 27, 30, 31) reported the total number of CoV-related research keywords (132–216). Most of the included bibliometric analyses showed that the main research fields of the CoV-related research focused on basic medical sciences (virology, microbiology, biochemistry & molecular biology, immunology, pharmacology, and pharmacy), clinical medicine (infectious diseases, pediatrics, and the respiratory system), veterinary sciences, and public health (public, environmental, and occupational health). The research hotpots mainly focused on the mechanisms, pathology, epidemiology, clinical diagnosis, and treatment of the coronavirus in MERS-CoV and SARS-Cov (Table 5, Appendix, Supplementary Table 6).

Table 5.

The findings of the main research topics in the published bibliometric analyses.

References Subject Main research topics Conclusions
(11) Focus on virology;
Public health;
Drugs and other hotspot fields;
Uncovers changes in the direction of coronavirus research.		 1. Public health, preventive medicine and epidemiology;
2. Virus detection and clinical diagnosis;
3. Some immunological and pharmaceutical research.		 NR
(33) NR 1. Clinical research;
2. Pathogenesis research;
3. Virological research;
4. Treatment;
5. Origin and transmission research.		 Notably, COVID-19 must become the research hotspot of coronavirus research, and clinical research on COVID-19 may be the key to defeating this epidemic.
(9) The most frequently assigned research fields are virology (2140);
Infectious diseases (899);
Veterinary sciences (720);
Microbiology (622);
Immunology (558).		 1. The molecular and biological topics;
2. outlines the articles dealing with the SARS epidemic;
3. Combines the articles dealing with the MERS epidemic;
4. Focuses on the spike protein that is characteristic of CoV, its pathogenesis, and its connection to the other clusters.		 The results underline the need for sustainable and forward-looking approaches that should not end with the containment of COVID-19.
(36) The top six research areas were virology (2957);
Infectious diseases (1594);
Immunology (1306);
Microbiology (1182);
Veterinary sciences (1163);
Biochemistry & molecular biology (1004).		 1. Virology (including molecular, biology, and immunology);
2. Infectious diseases (including medicine, medical, and clinical);
3. Veterinary medicine.		 The international cooperation is an important way to accelerate research progress and achieve success. Developing corresponding vaccines and drugs are the current hotspots and research directions.
(37) NR 1. The biological and virologic characteristics of coronavirus, including essential factors of infection and transmission routes during the outbreaks of SARS and MERS, as well as clinical features;
2. Some types of coronavirus spread among animals and humans;
3. Primary infection of coronavirus in mammals and birds is confined to the upper respiratory and gastrointestinal system;
4. The entrance into human body of SARS-CoV depends on the ACE2 receptor, while the spike protein functions as the adaptor;
5. The evolution based on the mutation of coronavirus RNA caused different symptoms to human kind.		 More research on prevention and treatment is needed according to an analysis of term density.
(30) Mainly involve basic medical sciences (virology, microbiology, biochemistry & molecular biology, immunology, pharmacology, & pharmacy);
Clinical medicine (infectious diseases, pediatrics, respiratory system);
Veterinary sciences;
Public health (public, environmental, and occupational health).		 1. Mainly about respiratory viruses, which illustrated viral respiratory infections from the angle of the clinic;
2. Mostly about the genetic aspects of various coronaviruses;
3. Mainly about SARS-CoV;
4. Mainly about immunity;
5. Mostly about MERS-CoV.		 Bibliometric analysis of the literature shows the research on coronavirus boomed when a novel coronavirus triggered outbreaks in people. With the end of the epidemic, the research tended to be cooling. Virus identification, pathogenesis, and coronavirus-mediated diseases attracted much attention. We must continue studying the viruses after an outbreak ended.
(32) Virology;
Veterinary sciences;
Infectious diseases.		 1. “Pathological research;”
2. “Epidemiology research;”
3. “Clinical research;”
4. “Mechanism research.”		 The outbreak of the epidemic could promote coronavirus research, meanwhile, coronavirus research contributes to overcoming the epidemic. Attention should be drawn to the latest popular research, including “Spike protein,” “Receptor binding domain,” and “Vaccine.” Therefore, more and more efforts will be put into mechanism research and vaccine research and development, which can be helpful to deal with the epidemic.
(27) NR 1. The biological and virologic characteristics of coronavirus, including essential factors of infection and transmission routes during the outbreaks of SARS and MERS, as well as clinical features; While in the 1980s, USA and developed countries from Europe were major source countries and the virus was identified only as an animal disease in the literature and its biological and genetic structure was investigated, in
2. Some types of coronaviruses spread among animals and humans;
3. Primary infection of coronavirus in mammals and birds is confined to the upper respiratory and gastrointestinal system;
4. The entrance into human body of SARS-CoV depends on the ACE2 receptor, while the spike protein functions as the adaptor;
5. The evolution based on the mutation of coronavirus RNA caused different symptoms to human kind.		 the 2000s, China became a major contributor of coronavirus literature because the SARS outbreak originated from southern China. Almost all most-cited publications in this period are related to SARS and the ACE2 protein.
(27) NR NR NR
(27) NR 1. Coronavirus;
2. Mouse hepatitis virus;
3. Transmissible gastroenteritis virus;
4. Rotavirus;
5. Cat.		 NR
(27) NR 1. “Coronavirus;”
2. “SARS;”
3. “SARS coronavirus;”
4. “SARSCoV.”		 NR
(27) NR 1. “Saudi Arabia;”
2. “MERS-CoV;”
3. “Outbreak;”
4. “Vaccine;”
5. “Camel;” 6. “Zoonosis.”		 NR
(26) Infectious diseases (5341; 83.14%);
Microbiology (5034; 78.36%);
Virology (4956; 77.14%);
Biochemistry molecular biology (4195; 65.30%);
Genetics heredity (3191; 49.67%) etc.		 The most commonly used keywords were “Coronavirus” followed by “Virus,” “Sars,” and “Infection.” The results of the study showed that the growth pattern was not uniform, USA, and the University of Hong Kong have played a major role in the contribution of Coronavirus research. Even though this depicts a higher scientific growth, it is an alarming sign to the community for preparedness. Under the prevailing situation of seeking better prevention, treatment and vaccination for COVID-19, in-depth research in the above portrayed metrics would be an added knowledge for the researchers.
(34) NR 1. Virus and coronavirus complementary research;
2. Virus and coronavirus types and strains.		 This research serves as a framework to strengthen existing research lines and develop new ones, establishing synergistic relationships that were not visible without the maps generated herein.
(31) NR NR Independent of the outcome of the current COVID-19 outbreak, we believe that measures should be taken to encourage sustained research in the field.
(35) The treatment hot spots focused on preventing virus adsorption, inhibiting the virus gene nucleic acid replication, transcription and translation. 1. CoVs epidemiology;
2. Basic research;
3. Drug development.		 Through the visualization analysis of knowledge graph, the development trend and hot spots of CoVs therapy research could be well observed. In this study, the degree of attention in the field of CoVs treatment showed periodic changes, related to the outbreak of new CoVs, and the country, institutions and the author were closely related. The treatment hot spots focused on preventing virus adsorption, inhibiting the virus gene nucleic acid replication, transcription and translation in order to develop new targets of drug.
(38) Virology (3205, 29.5);
Infectious Diseases (1442, 13.3);
Veterinary Science (1391, 12.8);
Immunology (1280, 11.8);
Biochemistry Molecular Biology (1270, 11.7) etc.		 NR Future studies need to include articles from other quality databases as well in order to achieve generalizations. Future researchers also need to focus their attention now on experimental studies on COV.
Open in a new tab

COVID-19, Coronavirus disease 2019; NR, not reported; SARS, severe acute respiratory syndrome; MERS, Middle East Respiratory Syndrome; CoV, coronavirus; ACE2, angiotensin-converting enzyme 2.

Discussion

We found that CoV-related publications showed two steep upward trajectories in 2003–2004 and 2012–2014. The research hotpots mainly focused on the mechanisms, pathology, epidemiology, clinical diagnosis, and treatment of the coronavirus in MERS-CoV and SARS-Cov. The most contributions to CoV-related research were from the USA and China in terms of the country; the University of Hong Kong in terms of the institute; and Yuen KY from the University of Hong Kong, in terms of the author.

The outbreak of SARS and MERS had a vital impact on the number of CoV-related publications. This study and included bibliometric analyses indicated that the number of CoV-related publications showed two steep upward trajectories from 2003 to 2004 and from 2012 to 2014, separately. The trends were consistent with the outbreak of the life-threatening SARS and MERS. The first case of SARS was identified on November 16, 2002, in China (39). The MERS-CoV was first identified in Saudi Arabia in April 2012, and cases have been confirmed every year with some significant rises in 2014, 2015, and 2019 (40). Until 30 June 2019, the majority of cases (84%) had been reported in Saudi Arabia (41). Since they are the places where the virus first appeared, China (No. publications = 2,754) and Saudi Arabia (No. publications = 422) have extensively studied CoV, and their number of publications are ranked 2nd and 11th respectively.

Overall, the USA and China played an important role in CoV-related research, followed by the Netherlands and England. This study found the USA and China were the most contributing countries in terms of STC, h-index, and NCMCI, which was supported by a previous study (20). This study showed that some institutes in the USA, China, and the Netherlands formed close cooperative relationships with other institutes. Because the USA is leading global scientific production, and the effort of the USA to foster international cooperation on CoV-related disease.

Keywords cluster analyses showed that the main research fields of the CoV-related research focused on basic medical sciences (virology, microbiology, biochemistry & molecular biology, immunology, pharmacology, and pharmacy), clinical medicine (infectious diseases, pediatrics, and the respiratory system), veterinary sciences, and public health (public, environmental, and occupational health). The research hotpots mainly focused on the mechanism, pathology, epidemiology, clinical diagnosis, and treatment of the coronavirus in MERS-CoV and SARS-Cov. These findings were in line with the findings of other published bibliometric analyses included in this study. However, the complete research process of virus includes the following: (1) studying the structure and function of the virus genome to fully understand the general morphology and structural characteristics of the virus; (2) exploring the replication, gene expression, and regulatory mechanism of the virus genome, to reveal the molecular nature of the virus infection and disease-causing; (3) researching and developing the virus genetic engineering vaccine and antiviral drugs; (4) studying the diagnosis, prevention, and treatment scheme of the virus infection disease (42, 43). This study showed the current research on CoV mainly focused on the first two stages of virus research. Therefore, there still was a lack of enough research on the related clinical, epidemiological, diagnostic, and therapeutic aspects (44). As the WHO recommended, drugs and vaccines were considered to need accelerated research and development (45), and research on the diagnosis, vaccines, and treatment options for CoV-related diseases should be strengthened (46).

Yuen KY from the University of Hong Kong contributed most to Cov-related research, especially in the fields of virology and microbiology. Followed by Baric RS and Drosten C, both of whom were members of the CoV Study Group (CSG) and assessed the novelty of the human pathogen tentatively named SARS-CoV-2 (47). The research of the CSG will improve understanding of virus-host interactions in an ever-changing environment and enhance our preparedness for future outbreaks (47). In the future, CoV-related researchers can collaborate to conquer the virus.

Strengths and Limitations

To our best knowledge, this is the first systematic review of bibliometric analysis in global coronavirus research trends before COVID-19. We also explored the top-5 research areas of the top-10 countries and top-10 authors in this bibliometric analysis.

However, our study has some limitations.Firstly, for the bibliometric analysis,we only searched WOS, which may lead to the omission of some important studies (48–50). Secondly, some of the data we analyzed were automatically extracted from the downloaded publications by the software, such as author names. Since the software could not distinguish between authors with the same name, this might affect the results of our analyses. Thirdly, for the systematic review, the assessment of the risk of bias for the included studies was important, but we did not conduct the risk of bias assessment for lack of a valid assessment tool.

Conclusions

CoV-related publications before COVID-19 have shown a rapidly increasing trend. The USA and China have played a vital role in CoV-related researches. Yuen KY from the University of Hong Kong has made contributions. The research topics mainly involved the mechanisms, pathology, epidemiology, clinical diagnosis, and treatment of the coronavirus in MERS-CoV and SARS, and more researchers should focus on the prevention, diagnosis, and treatment in the future.

Author Contributions

KY, PY, SW, and ML were responsible for the conception and design of the study. PY was in charge of the literature search data acquisition. PY, ML, ZL, JL, XH, YB, and YX collected, analyzed, and interpreted the data and wrote the first draft of the manuscript. YL was responsible for the editing and standardization of the tables and figures and gave critical advice on the manuscript. All authors reviewed the manuscript for important intellectual content and approved the final version for publication.

Funding

This work was supported by the Key Project of the Social Science Fund of Gansu Province: Social Research on the Response to COVID-19 in Gansu Province (Grant No. 20ZD016) and Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2020-sp14).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2021.729138/full#supplementary-material

Click here for additional data file. (967.7KB, pdf)

References

  • 1.WHO . Coronaviruses. (2020). Available online at: https://www.who.int/health-topics/coronavirus (accessed Febuary 10, 2020).
  • 2.Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, et al. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells. (2021) 10:821. 10.3390/cells10040821 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. (2019) 17:181–92. 10.1038/s41579-018-0118-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. (2020) 25:1–6. 10.2807/1560-7917.ES.2020.25.5.2000062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Liu P, Niu R, Chen J, Tang Y, Tang W, Xu L, et al. Epidemiological and clinical features in patients with coronavirus disease 2019 outside of Wuhan, China: special focus in asymptomatic patients. PLoS Negl Trop Dis. (2021) 15:e0009248. 10.1371/journal.pntd.0009248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. (2020) 81:1–9. 10.1016/j.jinf.2020.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li Y, Cao L, Zhang Z, Hou L, Qin Y, Hui X, et al. Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping. J Clin Epidemiol. (2021) 135:17–28. 10.1016/j.jclinepi.2021.02.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Li J, Du W, Yan P, Yang K. [Subject topics and dissemination clustering of COVID-19 epidemic studies at home and abroad]. Libr Inf. (2021) 67–74. 10.11968/tsyqb.1003-6938.2021025 [DOI] [Google Scholar]
  • 9.Klingelhöfer D, Braun M, Brüggmann D, Groneberg DA. Coronavirus: an insight into global research until outbreak of COVID-19 and its implications for the future. J Glob Health. (2020) 10:020508. 10.7189/jogh.10.020508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Goh S. Who will guard the guards? Covid-19 research may be incomplete, but experts are vital during this pandemic. BMJ. (2020) 370:m2658. 10.1136/bmj.m2658 [DOI] [PubMed] [Google Scholar]
  • 11.Deng Z, Chen J, Wang T. Bibliometric and visualization analysis of human coronaviruses: prospects and implications for COVID-19 research. Front Cell Infect Microbiol. (2020) 10:581404. 10.3389/fcimb.2020.581404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Usman M, Ho YS. A bibliometric study of the fenton oxidation for soil and water remediation. J Environ Manage. (2020) 270:110886. 10.1016/j.jenvman.2020.110886 [DOI] [PubMed] [Google Scholar]
  • 13.Deng Z, Wang H, Chen Z, Wang T. Bibliometric analysis of dendritic epidermal T Cell (DETC) research from 1983 to 2019. Front Immunol. (2020) 11:259. 10.3389/fimmu.2020.00259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Global I. What is Bibliometric Analysis. (2020). Available online at: https://www.igi-global.com/dictionary/education-literature-development-responsibility/2406 (accessed March 1, 2020).
  • 15.Blakeman K. Bibliometrics in a digital age: help or hindrance. Sci Prog. (2018) 101:293–310. 10.3184/003685018X15337564592469 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zyoud SH. Global research trends of middle east respiratory syndrome coronavirus: a bibliometric analysis. BMC Infect Dis. (2016) 16:1–7. 10.1186/s12879-016-1600-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang Z, Chen Y, Cai G, Jiang Z, Liu K, Chen B, et al. A bibliometric analysis of pubmed literature on middle east respiratory syndrome. Int J Environ Res Public Health. (2016) 13:1–9. 10.3390/ijerph13060583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Beal J, Mitchell T, Wyschogrod D, Manthey J, Clore A. Highly distinguished amino acid sequences of 2019-nCoV (Wuhan Coronavirus). bioRxiv. (2020). 10.1101/2020.01.31.929497 [DOI] [Google Scholar]
  • 19.Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens. Global Health. (2017) 13:9–29. 10.1186/s12992-017-0233-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, Ramirez-Ocampo S, Paniz-Mondolfi A, Rabaan AA, et al. SARS-CoV, MERS-CoV and now the 2019-novel CoV: have we investigated enough about coronaviruses?-a bibliometric analysis. Travel Med Infect Dis. (2020) 33:101566. 10.1016/j.tmaid.2020.101566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Thomson Reuters. Journal Citation Reports. (2020). Available online at: https://jcr.clarivate.com/JCRJournalHomeAction.action (accessed January 10, 2020).
  • 22.Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in citespace. Expert Opin Biol Ther. (2012) 12:593–608. 10.1517/14712598.2012.674507 [DOI] [PubMed] [Google Scholar]
  • 23.van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. (2010) 84:523–38. 10.1007/s11192-009-0146-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shi J-g, Miao W, Si H. Visualization and analysis of mapping knowledge domain of urban vitality research. Sustainability. (2019) 11:988. 10.3390/su11040988 [DOI] [Google Scholar]
  • 25.Wrigley J, Carden V, von Isenburg M. Bibliometric mapping for current and potential collaboration detection. J Med Libr Assoc. (2019) 107:597–600. 10.5195/jmla.2019.764 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Joshua V, Sivaprakasam S. Coronavirus: bibliometric analysis of scientific publications from 1968 to 2020. Med J Islam Repub Iran. (2020) 34:64. 10.47176/mjiri.34.64 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Enel E, Topal FEJDM, Preparedness PH. Holistic Analysis of Coronavirus Literature: A Scientometric Study of the Global Publications Relevant to SARS-CoV-2 (COVID-19), MERS-CoV (MERS) and SARS-CoV (SARS). Disaster Med Public Health Prep. (2020) 1–15. 10.1017/dmp.2020.300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. (2003) 348:1953–66. 10.1056/NEJMoa030781 [DOI] [PubMed] [Google Scholar]
  • 29.Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. (2003) 348:1967–76. 10.1056/NEJMoa030747 [DOI] [PubMed] [Google Scholar]
  • 30.Jia Q, Shi S, Yuan G, Shi J, Shi S, Hu Y. Analysis of knowledge bases and research hotspots of coronavirus from the perspective of mapping knowledge domain. Medicine. (2020) 99:e20378. 10.1097/md.0000000000020378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kagan D, Moran-Gilad J, Fire M. Scientometric trends for coronaviruses and other emerging viral infections. Gigascience. (2020) 9:1–17. 10.1093/gigascience/giaa085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mao XJ, Guo L, Fu PF, Xiang C. The status and trends of coronavirus research A global bibliometric and visualized analysis. Medicine. (2020) 99:e20137. 10.1097/md.0000000000020137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tao Z, Zhou S, Yao R, Wen K, Da W, Meng Y, et al. COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis. Ann Transl Med. (2020) 8:528. 10.21037/atm.2020.04.26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Herrera-Viedma E, Lopez-Robles JR, Guallar J, Cobo MJ. Global trends in coronavirus research at the time of Covid-19: a general bibliometric approach and content analysis using SciMAT. Profesional De La Informacion. (2020) 29:e290322. 10.3145/epi.2020.may.22 [DOI] [Google Scholar]
  • 35.Yi W, Wang Y, Tang J, Xiong X, Zhang Y, Yan S. [Visualization analysis on treatment of coronavirus based on knowledge graph]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. (2020) 32:279–86. 10.3760/cma.j.cn121430-20200225-00200 [DOI] [PubMed] [Google Scholar]
  • 36.Zhai F, Zhai Y, Cong C, Song T, Xiang R, Feng T, et al. Research progress of coronavirus based on bibliometric analysis. Int J Environ Res Public Health. (2020) 17:3766. 10.3390/ijerph17113766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhou Y, Chen L. Twenty-year span of global coronavirus research trends: a bibliometric analysis. Int J Environ Res Public Health. (2020) 17:3082. 10.3390/ijerph17093082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ali A, AhmadHakak I, Amin F. Assessing the coronavirus research output: a bibliometric analysis. Glob Bus Rev. (2020). 10.1177/097215092097511632328369 [DOI] [Google Scholar]
  • 39.Zhong NS, Zheng BJ, Li YM, Poon Xie ZH, Chan KH, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, people's republic of China, in February, 2003. Lancet. (2003) 362:1353–8. 10.1016/S0140-6736(03)14630-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.CDC E. European Centre for Disease Prevention and Control. Distribution of confirmed MERS-CoV cases. (2019). Available online at: https://www.ecdc.europa.eu/en/middle-east-respiratory-syndrome-coronavirus-mers-cov-situation-update (accessed Febuary 16, 2020).
  • 41.WHO World Health Organization . WHO MERS Global Summary and Assessment of Risk. (2019). Available online at: https://apps.who.int/iris/bitstream/handle/10665/326126/WHO-MERS-RA-19.1-eng.pdf?ua=1 (accessed Febuary 17, 2020).
  • 42.Solomon T, Lewthwaite P, Perera D, Cardosa MJ, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. (2010) 10:778–90. 10.1016/S1473-3099(10)70194-8 [DOI] [PubMed] [Google Scholar]
  • 43.Lau JY. Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet. (1993) 342:1335–40. 10.1016/0140-6736(93)92249-S [DOI] [PubMed] [Google Scholar]
  • 44.Momattin H, Al-Ali AY, Al-Tawfiq JA. A systematic review of therapeutic agents for the treatment of the middle east respiratory syndrome coronavirus (MERS-CoV). Travel Med Infect Dis. (2019) 30:9–18. 10.1016/j.tmaid.2019.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.WHO World Health Organization . 2018 Annual review of diseases prioritized under the Research andDevelopment Blueprint. (2018). Available online at: https://www.who.int/news-room/events/detail/2018/02/06/default-calendar/2018-annual-review-of-diseases-prioritized-under-the-research-anddevelopment-blueprint (accessed March 1, 2020).
  • 46.Zarocostas J. What next for the coronavirus response? Lancet. (2020) 395:401. 10.1016/S0140-6736(20)30292-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. (2020) 5:536–44. 10.1038/s41564-020-0695-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ge L, Tian J-h, Li Y-n, Pan J-x, Li G, Wei D, et al. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. J Clin Epidemiol. (2018) 93:45–55. 10.1016/j.jclinepi.2017.10.012 [DOI] [PubMed] [Google Scholar]
  • 49.Lun Li, Jinhui Tian, Hongliang Tian, et al. Network meta-analyses could be improved by searching more sources and by involving a librarian. J Clin Epidemiol. (2014) 67:1001–7. 10.1016/j.jclinepi.2014.04.003 [DOI] [PubMed] [Google Scholar]
  • 50.Yao L, Sun R, Chen YL, Wang Q, Yang K. The quality of evidence in Chinese meta-analyses need to be Improved. J Clin Epidemiol. (2016) 74:73–9. 10.1016/j.jclinepi.2016.01.003 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (967.7KB, pdf)

Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES